EQS-Adhoc: Drägerwerk AG & Co. KGaA: Annual forecast raised again
EQS-Ad-hoc: Drägerwerk AG Co. KGaA / Key word(s): Change in Forecast Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG Co. KGaA: Annual forecast raised again Lübeck, December 13, 2023 – Dräger's net sales and earnings in the current fourth quarter of 2023 have so far exceeded the Company’s expectations. This is due to continued high net sales recognition with high-margin products and effective cost management. Dräger therefore expects to exceed its previous forecast for fiscal year 2023. Accordingly, net sales could even grow by more than 11.0 percent net of currency effects, which corresponds to nominal growth of more than 8.5 percent, and EBIT could reach more than 4.0 percent of consolidated net sales. In October, Dräger had already raised its forecast for the EBIT margin to between 2.0 and 4.0 percent due to the positive business development. The original forecast range for fiscal year 2023 was for currency-adjusted net sales growth of between 8.0 and 11.0 percent and an EBIT margin of 0.0 to 3.0 percent. The preliminary figures for the 2023 fiscal year will be published in mid-January 2024. The 2023 Annual Report will be published on March 7, 2024.
Drägerwerk AG Co. KGaA
Investor Relations:
Corporate Communications:
Disclaimer End of Inside Information
13-Dec-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Drägerwerk AG Co. KGaA |
Moislinger Allee 53-55 | |
23558 Lübeck | |
Germany | |
Phone: | +49 (0)451 882-0 |
Fax: | +49 (0)451 882-2080 |
E-mail: | [email protected] |
Internet: | www.draeger.com |
ISIN: | DE0005550602, DE 000 555 063 6, DE 000 555 071 9 |
WKN: | 555060, 555063 Vorzüge, 555071 Genussschein D |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Stuttgart, Tradegate Exchange |
EQS News ID: | 1796357 |
End of Announcement | EQS News Service |
|
1796357 13-Dec-2023 CET/CEST
Drägerwerk AG & Co. KGaA ST Stock
Currently there is a rather positive sentiment for Drägerwerk AG & Co. KGaA ST with 3 Buy predictions and 0 Sell predictions.
As a result the target price of 66 € shows a positive potential of 47.32% compared to the current price of 44.8 € for Drägerwerk AG & Co. KGaA ST.